Bolt Biotherapeutics Inc (BOLT)
0.668
+0.01
(+1.44%)
USD |
NASDAQ |
Nov 04, 16:00
0.6577
-0.01
(-1.54%)
After-Hours: 20:00
Bolt Biotherapeutics Profit Margin (Quarterly): -1.66K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.66K% |
| March 31, 2024 | -205.0% |
| December 31, 2023 | -857.0% |
| September 30, 2023 | -643.1% |
| June 30, 2023 | -1.26K% |
| March 31, 2023 | -929.9% |
| December 31, 2022 | -1.42K% |
| September 30, 2022 | -1.03K% |
| June 30, 2022 | -1.63K% |
| March 31, 2022 | -2.91K% |
| Date | Value |
|---|---|
| December 31, 2021 | -5.35K% |
| September 30, 2021 | -3.11K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -16.51K% |
| March 31, 2020 | -5.26K% |
| December 31, 2019 | -14.40K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.51K%
Minimum
Jun 2020
-205.0%
Maximum
Mar 2024
-3.81K%
Average
-1.63K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| SeaStar Medical Holding Corp | -- |
| CVS Health Corp | 1.94% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.72% |
| Return on Assets | -41.72% |
| Return on Invested Capital | -57.72% |
| Operating Margin (Quarterly) | -1.49K% |
| Return on Net Operating Assets | -275.8% |